Search
Search
About
Log in
Join
Experiences with
Interferon alfa-2b
Posts
Communities
1,031 public posts
Filter results
Hypercalcemia
Hi all. I have been diagnosed with mild hypercalcemia and a raised PTH level. I was sent by my heam for head to toe bone x-rays, which thank god didn't show multiple myloma, or other cancers and am now waiting to see the endocrinologist as an urgent referral. I know it's to do with the thyroid glands
Hi all. I have been diagnosed with mild hypercalcemia and a raised PTH level. I was sent by my heam for head to toe bone x-rays, which thank god didn't show multiple myloma, or other cancers and am now waiting to see the endocrinologist as an urgent referral. I know it's to do with the thyroid glands
harleydavidson
in
MPN Voice
9 years ago
Interferon monotherapy effective in patients with HCV thalassemia major
Interferon
alfa
-
2b
or pegylated
interferon
-
alfa
-
2b
monotherapies were effective treatment options in patients with hepatitis C virus thalassemia major, according to study results.
Interferon
alfa
-
2b
or pegylated
interferon
-
alfa
-
2b
monotherapies were effective treatment options in patients with hepatitis C virus thalassemia major, according to study results.
kcohen
in
HFI Connect - Hepatitis
9 years ago
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
The market for the new class of hepatitis-C drugs is becoming more crowded as a higher percentage of patients seek out therapies with shorter treatment durations and drugmakers pursue indications for more stubborn forms of the infection. Gilead Sciences, which developed Sovaldi and Harvoni, the current
The market for the new class of hepatitis-C drugs is becoming more crowded as a higher percentage of patients seek out therapies with shorter treatment durations and drugmakers pursue indications for more stubborn forms of the infection. Gilead Sciences, which developed Sovaldi and Harvoni, the current
kcohen
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
FDA approves Technivie for treatment of chronic hepatitis C genotype 4
The U.S. Food and Drug Administration today approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and poor liver function (cirrhosis). Technivie in combination
The U.S. Food and Drug Administration today approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and poor liver function (cirrhosis). Technivie in combination
kcohen
in
HFI Connect - Hepatitis
9 years ago
Waving Hullo!
hi there! Brand new here. I decided it was time to get some more support now that I have been placed on the transplant list. I was diagnosed with end stage liver disease 3 years ago, consisting of Fatty Liver, Hepatitis C and Alcoholic cirrhosis. I have been sober nearly 7 years, but did not get sick
hi there! Brand new here. I decided it was time to get some more support now that I have been placed on the transplant list. I was diagnosed with end stage liver disease 3 years ago, consisting of Fatty Liver, Hepatitis C and Alcoholic cirrhosis. I have been sober nearly 7 years, but did not get sick
dckimberly
in
British Liver Trust
9 years ago
ABBVIE ANNOUNCES NEW PHASE 3B RESULTS IN GENOTYPE 1B CHRONIC HEPATITIS C PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced TURQUOISE-III study results demonstrating 100 percent (n=60/60) sustained virologic response at 12 weeks post-treatment (SVR12) in genotype 1b (GT1b) chronic hepatitis C virus (HCV) infected adult patients with compensated liver
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced TURQUOISE-III study results demonstrating 100 percent (n=60/60) sustained virologic response at 12 weeks post-treatment (SVR12) in genotype 1b (GT1b) chronic hepatitis C virus (HCV) infected adult patients with compensated liver
kcohen
in
HFI Connect - Hepatitis
9 years ago
U.S. Eyes Cuba's Lung Cancer Vaccine and Hepatitis Research
For several years, Cuba has had a promising vaccine against lung cancer, and the United States wants it. However, that’s not the only biotech invention that the Caribbean nation has up its sleeve—for several years, U.S. health experts have also been eyeing the island’s hepatitis research, Wired reports
For several years, Cuba has had a promising vaccine against lung cancer, and the United States wants it. However, that’s not the only biotech invention that the Caribbean nation has up its sleeve—for several years, U.S. health experts have also been eyeing the island’s hepatitis research, Wired reports
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Hepatitis C - The Long Goodbye
The long goodbye is often used to describe the drawn out fading of a person’s mind, who is suffering from Alzheimer’s disease. But for my Mom, it was because of Hepatitis C. My Mom worked as a hospital lab technician for most of her career. She remembered accidentally sticking her hand, with the contaminated
The long goodbye is often used to describe the drawn out fading of a person’s mind, who is suffering from Alzheimer’s disease. But for my Mom, it was because of Hepatitis C. My Mom worked as a hospital lab technician for most of her career. She remembered accidentally sticking her hand, with the contaminated
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Coffee and the Liver
First let’s talk about the good news—the possible health benefits: Liver Fibrosis / HCV Disease Progression: In a review of 177 patients—121 patients with HCV who drank about 2 ¼ cups of coffee a day were found to have reduced levels of liver fibrosis. The results were only found in those who drank
First let’s talk about the good news—the possible health benefits: Liver Fibrosis / HCV Disease Progression: In a review of 177 patients—121 patients with HCV who drank about 2 ¼ cups of coffee a day were found to have reduced levels of liver fibrosis. The results were only found in those who drank
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Preparing for Hepatitis C Treatment: Part 1by Alan Franciscus
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%.
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Management of Primary Hypothyroidism Statement by the British Thyroid Association Executive Committee
Any comments? [i]Clin Endocrinol (Oxf). 2015 May 23. doi: 10.1111/cen.12824. [Epub ahead of print]
Management of Primary Hypothyroidism Statement by the British Thyroid Association Executive Committee.
Okosieme O1, Gilbert J2, Abraham P3, Boelaert K4, Dayan C5, Gurnell M6, Leese G7, McCabe
Any comments? [i]Clin Endocrinol (Oxf). 2015 May 23. doi: 10.1111/cen.12824. [Epub ahead of print]
Management of Primary Hypothyroidism Statement by the British Thyroid Association Executive Committee.
Okosieme O1, Gilbert J2, Abraham P3, Boelaert K4, Dayan C5, Gurnell M6, Leese G7, McCabe
helvella
Thyroid UK
in
Thyroid UK
9 years ago
Exviera, Viekirax combination added benefit for patients with HCV without cirrhosis
The dossier assessment is a procedural part of the Reform of the Market for Medicinal Products Act, overseen by the Federal Joint Committee (G-BA). The G-BA conducts a commenting procedure once the dossier assessment is complete and then determines the extent of the added benefit determined by the Institute
The dossier assessment is a procedural part of the Reform of the Market for Medicinal Products Act, overseen by the Federal Joint Committee (G-BA). The G-BA conducts a commenting procedure once the dossier assessment is complete and then determines the extent of the added benefit determined by the Institute
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Preparing for Hepatitis C Treatment: Part 1by Alan Franciscus
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Preparing for Hepatitis C Treatment: Part 1by Alan Franciscus
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Sovaldi, Interferon and Ribavirin Cures Almost All Hep C Genotype 3
http://www.hepmag.com/articles/BOSON_genotype_3_2501_27135.shtml
http://www.hepmag.com/articles/BOSON_genotype_3_2501_27135.shtml
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Merck’s Hep C Meds Work Well in Treatment-Experienced People
Twelve weeks of Merck’s grazoprevir and elbasvir, plus ribavirin, cured nearly all treatment-experienced people with genotype 1 of hepatitis C virus (HCV) in a small trial, including those with cirrhosis. The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon,
Twelve weeks of Merck’s grazoprevir and elbasvir, plus ribavirin, cured nearly all treatment-experienced people with genotype 1 of hepatitis C virus (HCV) in a small trial, including those with cirrhosis. The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon,
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Auto Immune
Hi All, I have been suffering from uveitis caused by an auto immune response for the last seven years. None of my doctors are wanting to put a label on it, but I have had many other problems - such as livedo reticularis amongst other things. The steriods have stopped controlling the situation, as
Hi All, I have been suffering from uveitis caused by an auto immune response for the last seven years. None of my doctors are wanting to put a label on it, but I have had many other problems - such as livedo reticularis amongst other things. The steriods have stopped controlling the situation, as
tatbagend
in
LUPUS UK
9 years ago
The future for CLL?
In the last few years, we've seen some great advances in the efficacy of new treatments for CLL, with very encouraging progress towards a cure. There has even been talk that we may have achieved the breakthrough that Imatinib (perhaps better know as Gleevec) was for a sister leukaemia to CLL - CML or
In the last few years, we've seen some great advances in the efficacy of new treatments for CLL, with very encouraging progress towards a cure. There has even been talk that we may have achieved the breakthrough that Imatinib (perhaps better know as Gleevec) was for a sister leukaemia to CLL - CML or
AussieNeil
Partner
in
CLL Support
9 years ago
1
...
47
48
49
...
52
Next page
10
20
30
40
50
Filter results
Clear filters
Posted in
All communities
MPN Voice
784 results
My MSAA Community
39 results
British Liver Trust
28 results
View top 10 communities
Sort by
Most Relevant
Newest